Ledger.Open graph →
SEC Form D · Amendment · filed January 4, 2017

Petra Pharma Corp

Offering
$48.3M
Sold
$21.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Thong Le · New York, NYExec · Director · PromoterLindsay J. Rayle · New York, NYExec · PromoterBarbara J. Dalton · New York, NYDirectorDavid J. Mcelligott · New York, NYExec · PromoterSteve Gillis · New York, NYDirectorM. J. Erwin · New York, NYDirectorPaul J. Sekhri · New York, NYDirectorJoel J. Marcus · New York, NYDirectorDavid J. Schubert · New York, NYExec · PromoterKerwin Brandt · CHICAGO, ILDirectorMatthew R. Gottesdiener · Newton, MAExec · PromoterRobert O. Tatum, Jr · Hattiesburg, MSExec · PromoterIsrael E. Sendrovic · Fort Lee, NJDirectorLawrence R. Gottesdiener · Newton, MADirectorSam Yagan · CHICAGO, ILExec · PromoterClifford M. Weiner · Dallas, TXExec · Director · PromoterBeth H. Kinsley · Newton, MADirectorSuzanne D. Abair · Newton, MAExec · Director · PromoterTrent Dawson · KIRKLAND, WAExec · PromoterErik Anderson · KIRKLAND, WADirectorPatty Swenson · Mammoth Lakes, CAExec · Director · PromoterDavid P. Bordo · McMurray, PADirectorJames P. O'Neill · Naples, FLDirectorAndrew V. Sheehan · San Mateo, CAExec · PromoterD. L. King · San Mateo, CADirectorDrew E. Parker · Fort Lee, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗